Corpus Intelligence IC Memo — PUSHMATAHA HOSPITAL 2026-04-26 09:36 UTC
IC Memo — PUSHMATAHA HOSPITAL
Investment Committee Memorandum | OK | 42 beds | Grade D | EBITDA uplift $457K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PUSHMATAHA HOSPITAL

CCN 370083 | PUSHMATAHA, OK | 42 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

PUSHMATAHA HOSPITAL is a 42-bed rural/critical access in PUSHMATAHA, OK with $6.1M in net patient revenue and a -23.7% operating margin. The hospital serves a payer mix of 66.5% Medicare, 12.8% Medicaid, and 20.7% commercial.

Thesis: Turnaround. Our ML models identify $457K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -23.7% to -16.2% (+754bps).

Net Revenue HCRIS$6.1M
Current EBITDA COMPUTED$-1.4M
Operating Margin COMPUTED-23.7%
Occupancy HCRIS15.7%
Revenue / Bed COMPUTED$144K
Net-to-Gross HCRIS32.6%
Distress Probability ML61.4%

2. Market Context & Competitive Position

147
OK Hospitals
-8.8%
State Median Margin
92
Comparable Hospitals

OK has 147 Medicare-certified hospitals with a median operating margin of -8.8%. The target's margin of -23.7% places it below the state median. Among 92 size-comparable peers (21-84 beds), the median margin is -9.0%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (21-84), prioritizing same-state peers. 92 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PUSHMATAHA HOSPITAL (Target)OK42$6.1M-23.7%
STILLWATER MEDICAL CENTEROK52$270.2M-9.9%
ST ANTHONY SHAWNEE HOSPITALOK57$169.2M-6.1%
MCBRIDE CLINIC ORTHOPEDIC HOSPOK68$166.9M-5.0%
OKLAHOMA HEART HOSPITAL SOUTHOK43$148.5M-0.6%
OKLAHOMA SURGICAL HOSPITALOK74$146.2M17.7%
COMMUNITY HOSPITALOK45$143.9M21.7%
NORTHEASTERN HEALTH SYSTEMOK80$134.6M-9.6%
INTEGRIS HEALTH EDMONDOK77$119.4M-3.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $457K (754bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$127K+210bp18mo
Denial Rate Reduction12.0%6.5%$125K+206bp12mo
Cost to Collect4.5%2.5%$121K+200bp12mo
A/R Days Reduction5200.0%3800.0%$74K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+16bp6mo

5. EBITDA Bridge

Net Collection Rate
$127K
Denial Rate Reduction
$125K
Cost to Collect
$121K
A/R Days Reduction
$74K
Clean Claim Rate
$10K
Total EBITDA Uplift$457K
Current EBITDA$-1.4M
+ RCM Uplift+$457K
Pro Forma EBITDA$-982K
Current Margin-23.7%
Pro Forma Margin-16.2%
WC Released (1x)$233K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-2.2M$-4.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-2.2M$-6.1M0.00x-100.0%
Bull Case9.0x11.0x$-2.0M$-5.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-2.0M$-6.4M0.00x-100.0%
Bear Case11.0x10.0x$-2.4M$-6.5M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-2.4M$-7.9M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 66.5% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 15.7%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 61.4% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 92 hospitals with 21-84 beds
  • Same-state prioritization (n=93)
  • Comp margins: P25=-23.3% / P50=-9.0% / P75=3.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.